Chris Del Mar

发表

Why Cochrane should prioritise sharing data

David Moher, Luke Vale, Ben Goldacre, 2018, British Medical Journal.

Clinicians’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review

Chris Del Mar, T. Hoffmann, C. Del Mar, 2017, JAMA internal medicine.

Do Individualized Medication Effectiveness Tests (N-of-1 Trials) Change Clinical Decisions About Which Drugs to Use for Osteoarthritis and Chronic Pain?

Chris Del Mar, P. Glasziou, C. Nikles, 2005, American journal of therapeutics.

Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners

Chris Del Mar, D. English, C. Del Mar, 2004, The Medical journal of Australia.

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus

Keiji Fukuda, Andrew D Oxman, Holger J Schünemann, 2006, The Lancet Infectious Diseases.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

Tom Jefferson, Peter Doshi, Chris Del Mar, 2009, BMJ : British Medical Journal.

Physical interventions to interrupt or reduce the spread of respiratory viruses

Chris Del Mar, Tom Jefferson, Ruth Foxlee, 2011 .

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

Tom Jefferson, Peter Doshi, Chris Del Mar, 2012, PLoS medicine.

Computerisation in Australian general practice.

Chris Del Mar, C. Del Mar, T. Makkai, 2003, Australian family physician.